Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-000176-17Phase 2Completed
Phase 2, randomised, double-blind trial of terutroban in ischemic stroke, transient ischaemic attack (TIA) and Carotid artery disease (CAD) (2 arms), sponsored by Servier. Primary endpoint: Expression of biochemical markers of inflammation in carotid plaque. Started Jul 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-000176-17.